SIRPG

gene
On this page

Also known as bA77C3.1SIRP-B2SIRPgammaCD172g

Summary

SIRPG (signal regulatory protein gamma, HGNC:15757) is a protein-coding gene on chromosome 20p13, encoding Signal-regulatory protein gamma (Q9P1W8). Probable immunoglobulin-like cell surface receptor.

The protein encoded by this gene is a member of the signal-regulatory protein (SIRP) family, and also belongs to the immunoglobulin superfamily. SIRP family members are receptor-type transmembrane glycoproteins known to be involved in the negative regulation of receptor tyrosine kinase-coupled signaling processes. Alternatively spliced transcript variants encoding different isoforms have been described.

Source: NCBI Gene 55423 — RefSeq curated summary.

At a glance

  • Gene–disease (curated): male infertility with azoospermia or oligozoospermia due to single gene mutation (Limited, GenCC)
  • GWAS associations: 7
  • Clinical variants (ClinVar): 105 total — 1 likely-pathogenic
  • MANE Select transcript: NM_018556

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:15757
Approved symbolSIRPG
Namesignal regulatory protein gamma
Location20p13
Locus typegene with protein product
StatusApproved
AliasesbA77C3.1, SIRP-B2, SIRPgamma, CD172g
Ensembl geneENSG00000089012
Ensembl biotypeprotein_coding
OMIM605466
Entrez55423

Gene structure

Transcript identifiers

Ensembl transcripts: 8 — 6 protein_coding, 2 protein_coding_CDS_not_defined

ENST00000216927, ENST00000303415, ENST00000344103, ENST00000381580, ENST00000381583, ENST00000478145, ENST00000497407, ENST00000885694

RefSeq mRNA: 3 — MANE Select: NM_018556 NM_001039508, NM_018556, NM_080816

CCDS: CCDS13020, CCDS13021, CCDS33434

Canonical transcript exons

ENST00000303415 — 6 exons

ExonStartEnd
ENSE0000116559216291521629636
ENSE0000132816716576421657779
ENSE0000168125716352671635599
ENSE0000176586916361881636505
ENSE0000345972016490521649408
ENSE0000361053216302221630306

Expression profiles

Bgee: expression breadth ubiquitous, 149 present calls, max score 98.68.

FANTOM5 (CAGE): breadth broad, TPM avg 2.6774 / max 214.4057, expressed in 362 samples.

FANTOM5 promoters (8 alternative TSS)

Promoter IDTPM avgSamples expressed
1860262.6774362
1860441.9927118
1860430.462073
1860290.4102179
1860270.156470
1860280.154884
1860240.073037
1860420.00683

Top tissues by expression

272 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047398.68gold quality
buccal mucosa cellCL:000233688.99silver quality
lymph nodeUBERON:000002987.98gold quality
granulocyteCL:000009482.66gold quality
bloodUBERON:000017882.11gold quality
vermiform appendixUBERON:000115481.09gold quality
spleenUBERON:000210680.52gold quality
mucosa of transverse colonUBERON:000499179.70gold quality
epithelium of nasopharynxUBERON:000195177.10gold quality
caecumUBERON:000115375.55gold quality
left testisUBERON:000453373.15gold quality
right testisUBERON:000453472.89gold quality
small intestine Peyer’s patchUBERON:000345472.14gold quality
thymusUBERON:000237070.91silver quality
rectumUBERON:000105270.85gold quality
bone marrow cellCL:000209270.27gold quality
bone marrowUBERON:000237170.03gold quality
testisUBERON:000047370.00gold quality
gall bladderUBERON:000211069.29gold quality
small intestineUBERON:000210868.51gold quality
tendon of biceps brachiiUBERON:000818867.68gold quality
superficial temporal arteryUBERON:000161467.57silver quality
tonsilUBERON:000237267.43gold quality
parotid glandUBERON:000183166.92gold quality
tongue squamous epitheliumUBERON:000691965.77gold quality
trabecular bone tissueUBERON:000248362.89gold quality
transverse colonUBERON:000115761.56gold quality
skeletal muscle tissue of biceps brachiiUBERON:000450260.39gold quality
biceps brachiiUBERON:000150759.99gold quality
right coronary arteryUBERON:000162559.56gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes5.65
E-HCAD-30no68.00

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

41 targeting SIRPG, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4425100.0067.591049
HSA-MIR-6825-5P99.9669.813431
HSA-MIR-548AA99.9670.643753
HSA-MIR-548AP-3P99.9670.643753
HSA-MIR-548T-3P99.9670.643753
HSA-MIR-4731-5P99.8967.232537
HSA-MIR-6780A-5P99.8866.692776
HSA-MIR-4728-5P99.8569.394718
HSA-MIR-6785-5P99.8268.684428
HSA-MIR-1273H-5P99.7766.322471
HSA-MIR-3934-3P99.7665.511351
HSA-MIR-149-3P99.7268.223963
HSA-MIR-30B-3P99.7065.762325
HSA-MIR-3689A-3P99.7065.732306
HSA-MIR-3689B-3P99.7065.712311
HSA-MIR-3689C99.7065.712311
HSA-MIR-6779-5P99.7065.762363
HSA-MIR-6883-5P99.6968.053785
HSA-MIR-7106-5P99.5367.473574
HSA-MIR-1207-5P99.4969.112983
HSA-MIR-94099.3766.142064
HSA-MIR-6808-5P99.3166.232150
HSA-MIR-6893-5P99.3166.252119
HSA-MIR-504-3P99.3067.181745
HSA-MIR-450599.2767.812678
HSA-MIR-578799.2267.862628
HSA-MIR-3925-5P99.2167.901466
HSA-MIR-6799-5P99.1465.722093
HSA-MIR-4763-3P99.1067.832649
HSA-MIR-6877-3P98.9865.83560

Literature-anchored findings (GeneRIF, showing 8)

  • a novel member of the signal regulatory protein (SIRP) family- with unique characteristics from both alpha and beta genes- termed SIRPgamma (PMID:15294972)
  • CD47 is enriched at endothelial junctions, and its interaction with SIRPgamma is required for human T-cell transendothelial migration (PMID:18524990)
  • tumor necrosis factor receptor superfamily, member 14 (TNFRSF14) and signal regulatory protein, gamma (SIRPG) appear to contribute to gender difference in incidence of systemic lupus erythematosus. (PMID:19473566)
  • SIRPgamma in complex with FabOX117 forms a dimer in the crystal. Binding to the Fab fixes the position of domain 1 relative to domains 2/3 exposing a surface which favours formation of a homotypic dimer. (PMID:23826770)
  • The independent non-obstructive azoospermia risk alleles are driven by variants in the protein-coding sequence of the two genes, SIRPA and SIRPG. (PMID:24162948)
  • The SNP rs2281808 TT variant reduced SIRPgamma expression on T-cells. SIRPgamma(low) CD8 T-cells in CT and TT individuals were in a heightened effector state with lower activation threshold and had greater gene expression of molecules associated with migratory and cytotoxic potential. SIRPgamma(low) CD8 T-cells were deficient in transcription factors associated with long-term functional memory formation. (PMID:30337675)
  • Altered expression of SIRPgamma on the T-cells of relapsing remitting multiple sclerosis and type 1 diabetes patients could potentiate effector responses from T-cells. (PMID:32853219)
  • Genetic Control of Splicing at SIRPG Modulates Risk of Type 1 Diabetes. (PMID:34799406)

Cross-species orthologs

9 orthologs

OrganismSymbolGene ID
mus_musculusSirpaENSMUSG00000037902
mus_musculusSirpb1cENSMUSG00000074677
mus_musculusGm5150ENSMUSG00000078780
mus_musculusSirpdENSMUSG00000078783
mus_musculusSirpb1bENSMUSG00000095028
mus_musculusSirpb1aENSMUSG00000095788
rattus_norvegicusSirpaENSRNOG00000004763
rattus_norvegicusLOC100909964ENSRNOG00000043478
rattus_norvegicusAABR07008876.1ENSRNOG00000053292

Paralogs (4): SIRPB1 (ENSG00000101307), SIRPD (ENSG00000125900), SIRPB2 (ENSG00000196209), SIRPA (ENSG00000198053)

Protein

Protein identifiers

Signal-regulatory protein gammaQ9P1W8 (reviewed: Q9P1W8)

Alternative names: CD172 antigen-like family member B, Signal-regulatory protein beta-2

All UniProt accessions (1): Q9P1W8

UniProt curated annotations — full annotation on UniProt →

Function. Probable immunoglobulin-like cell surface receptor. On binding with CD47, mediates cell-cell adhesion. Engagement on T-cells by CD47 on antigen-presenting cells results in enhanced antigen-specific T-cell proliferation and costimulates T-cell activation.

Subunit / interactions. Interacts with CD47.

Subcellular location. Membrane.

Tissue specificity. Detected in liver, and at very low levels in brain, heart, lung, pancreas, kidney, placenta and skeletal muscle. Expressed on CD4+ T-cells, CD8+ T-cells, CD56-bright natural killer (NK) cells, CD20+ cells, and all activated NK cells. Mainly present in the paracortical T-cell area of lymph nodes, with only sparse positive cells in the mantle and in the germinal center of B-cell follicles. In the thymus, primarily expressed in the medulla on mature T-lymphocytes that have undergone thymic selection.

Isoforms (4)

UniProt IDNamesCanonical?
Q9P1W8-11yes
Q9P1W8-22
Q9P1W8-33
Q9P1W8-44

RefSeq proteins (3): NP_001034597, NP_061026, NP_543006 (=MANE)

Domains & families (InterPro)

IDNameType
IPR003597Ig_C1-setDomain
IPR003599Ig_subDomain
IPR007110Ig-like_domDomain
IPR013106Ig_V-setDomain
IPR013783Ig-like_foldHomologous_superfamily
IPR036179Ig-like_dom_sfHomologous_superfamily
IPR051755Ig-like_CS_ReceptorFamily

Pfam: PF07654, PF07686

UniProt features (48 total): strand 25, glycosylation site 4, disulfide bond 3, splice variant 3, domain 3, sequence variant 2, topological domain 2, helix 2, signal peptide 1, chain 1, transmembrane region 1, turn 1

Structure

Experimental structures (PDB)

2 structures.

PDBMethodResolution (Å)
2JJWX-RAY DIFFRACTION1.7
4I2XX-RAY DIFFRACTION2.48

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9P1W8-F185.930.70

Antibody-complex structures (SAbDab): 14I2X

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Disulfide bonds (3): 53–119, 168–226, 271–329

Glycosylation sites (4): 309, 317, 243, 268

Function

Pathways and Gene Ontology

Reactome pathways

4 pathways

IDPathway
R-HSA-202733Cell surface interactions at the vascular wall
R-HSA-391160Signal regulatory protein family interactions
R-HSA-109582Hemostasis
R-HSA-1500931Cell-Cell communication

MSigDB gene sets: 159 (showing top): GOBP_REGULATION_OF_CELL_ACTIVATION, GOBP_POSITIVE_REGULATION_OF_ENDOCYTOSIS, GOBP_VESICLE_MEDIATED_TRANSPORT, GOBP_CELL_CELL_SIGNALING, GOBP_REGULATION_OF_VESICLE_MEDIATED_TRANSPORT, GOBP_POSITIVE_REGULATION_OF_CELL_ADHESION, GOBP_CELL_CELL_ADHESION, GOBP_POSITIVE_REGULATION_OF_CELL_ACTIVATION, GOBP_POSITIVE_REGULATION_OF_PHAGOCYTOSIS, GOBP_REGULATION_OF_ENDOCYTOSIS, GOBP_LEUKOCYTE_CELL_CELL_ADHESION, GOBP_POSITIVE_REGULATION_OF_CELL_CELL_ADHESION, GOBP_REGULATION_OF_PHAGOCYTOSIS, GOBP_POSITIVE_REGULATION_OF_TRANSPORT, GOBP_REGULATION_OF_TRANSPORT

GO Biological Process (8): cell adhesion (GO:0007155), cell-cell signaling (GO:0007267), positive regulation of cell population proliferation (GO:0008284), negative regulation of cell population proliferation (GO:0008285), positive regulation of cell-cell adhesion (GO:0022409), intracellular signal transduction (GO:0035556), positive regulation of phagocytosis (GO:0050766), positive regulation of T cell activation (GO:0050870)

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)

Reactome top-level categories

Rollup of top-2 pathways:

CategoryPathways
Hemostasis1
Cell-Cell communication1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cell population proliferation2
regulation of cell population proliferation2
cellular process1
cell communication1
signaling1
positive regulation of cellular process1
negative regulation of cellular process1
regulation of cell-cell adhesion1
positive regulation of cell adhesion1
cell-cell adhesion1
intracellular anatomical structure1
signal transduction1
phagocytosis1
positive regulation of endocytosis1
regulation of phagocytosis1
T cell activation1
regulation of T cell activation1
positive regulation of lymphocyte activation1
positive regulation of leukocyte cell-cell adhesion1
binding1
membrane1
cell periphery1
cellular anatomical structure1

Protein interactions and networks

STRING

1428 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
SIRPGCD47Q08722998
SIRPGTYROBPO43914737
SIRPGCD3EP07766483
SIRPGLGALS9O00182447
SIRPGCD44P16070442
SIRPGSH2D1AO60880437
SIRPGSIRPAP78324434
SIRPGUBASH3AP57075431
SIRPGLCKP06239412
SIRPGTMIGD2Q96BF3354
SIRPGUBE2UQ5VVX9352
SIRPGRIPK1Q13546349
SIRPGCD6P30203348
SIRPGASAP1Q9ULH1348
SIRPGSLA2Q9H6Q3344

IntAct

12 interactions, top by confidence:

ABTypeScore
SIRPGCD47psi-mi:“MI:0915”(physical association)0.710
SIRPGCD47psi-mi:“MI:0407”(direct interaction)0.710
SIRPGFOSpsi-mi:“MI:0915”(physical association)0.560
SIRPGGATMpsi-mi:“MI:0915”(physical association)0.560
SIRPGSIRPApsi-mi:“MI:0915”(physical association)0.400

BioGRID (8): SIRPA (Affinity Capture-MS), SPCS2 (Affinity Capture-MS), LTF (Affinity Capture-MS), SIRPA (Affinity Capture-MS), LTF (Affinity Capture-MS), SIRPA (Affinity Capture-MS), SIRPG (Protein-peptide), SIRPG (Affinity Capture-MS)

ESM2 similar proteins: A0A140LHF2, A0JPB1, A8E0Y8, D3YX43, O00241, P01833, P01854, P01874, P01879, P01880, P0C788, P0DOX3, P0DOX4, P0DOX6, P0DUB1, P15083, P20273, P20768, P27931, P35590, P35916, P35917, P35969, P43121, P43303, P53767, P81265, Q06805, Q06806, Q15109, Q5FWR8, Q5TFQ8, Q5U5A3, Q62230, Q62786, Q6AYD4, Q8K135, Q8R2Y2, Q91ZT1, Q925F2

Diamond homologs: O00241, O46631, P01691, P01844, P01845, P01847, P01915, P04230, P04231, P18211, P18468, P18469, P18470, P20040, P78324, P97710, P97797, Q5JXA9, Q5TFQ8, Q9H106, Q9P1W8, Q9PWR4, P55899, Q29980, P01835, P35737, P01634, P01645, P01646, P01861, P20760, P01693, P01635, P01683, P14432

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

105 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic1
Uncertain significance74
Likely benign15
Benign2

Top pathogenic / likely-pathogenic (1)

Variant IDHGVSClassification
564643GRCh37/hg19 20p13(chr20:61568-2010334)x1Likely pathogenic

SpliceAI

1719 predictions. Top by Δscore:

VariantEffectΔscore
20:1477404:C:CCacceptor_gain1.0000
20:1630220:A:ACdonor_gain1.0000
20:1630221:C:CCdonor_gain1.0000
20:1630221:CAG:Cdonor_gain1.0000
20:1630221:CAGT:Cdonor_gain1.0000
20:1477399:TTTTG:Tacceptor_gain0.9900
20:1477400:TTTG:Tacceptor_gain0.9900
20:1477401:TTG:Tacceptor_gain0.9900
20:1477402:TG:Tacceptor_gain0.9900
20:1479804:T:TCacceptor_gain0.9900
20:1491270:CTTA:Cdonor_loss0.9900
20:1491271:TTACC:Tdonor_loss0.9900
20:1491272:TACCT:Tdonor_loss0.9900
20:1491273:A:ATdonor_loss0.9900
20:1491274:C:CTdonor_loss0.9900
20:1630213:TGTAC:Tdonor_loss0.9900
20:1630214:GTAC:Gdonor_loss0.9900
20:1630215:TACT:Tdonor_loss0.9900
20:1630216:ACTTA:Adonor_loss0.9900
20:1630217:CT:Cdonor_loss0.9900
20:1630218:TTACA:Tdonor_loss0.9900
20:1630219:TAC:Tdonor_loss0.9900
20:1630220:ACAGT:Adonor_gain0.9900
20:1630221:C:Adonor_loss0.9900
20:1630221:CA:Cdonor_gain0.9900
20:1630221:CAGTC:Cdonor_gain0.9900
20:1630307:C:CCacceptor_gain0.9900
20:1631228:G:Cdonor_gain0.9900
20:1649043:TGTAC:Tdonor_loss0.9900
20:1649044:GTACT:Gdonor_loss0.9900

AlphaMissense

2499 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
20:1635520:G:CF276L0.984
20:1635520:G:TF276L0.984
20:1635522:A:GF276L0.984
20:1636417:G:CF173L0.978
20:1636417:G:TF173L0.978
20:1636419:A:GF173L0.978
20:1649284:C:AW66C0.959
20:1649284:C:GW66C0.959
20:1649286:A:GW66R0.949
20:1649286:A:TW66R0.949
20:1649324:C:GC53S0.949
20:1649325:A:TC53S0.949
20:1636392:A:GW182R0.945
20:1636392:A:TW182R0.945
20:1649176:A:CF102L0.940
20:1649176:A:TF102L0.940
20:1649178:A:GF102L0.940
20:1649126:C:GC119S0.937
20:1649127:A:TC119S0.937
20:1649119:C:AK121N0.934
20:1649119:C:GK121N0.934
20:1649116:A:CF122L0.933
20:1649116:A:TF122L0.933
20:1649118:A:GF122L0.933
20:1636309:G:CS209R0.924
20:1636309:G:TS209R0.924
20:1636311:T:GS209R0.924
20:1649281:G:CF67L0.924
20:1649281:G:TF67L0.924
20:1649283:A:GF67L0.924

dbSNP variants (sampled 300 via entrez): RS1000130160 (20:1687227 G>A,T), RS1000145278 (20:1629266 C>G), RS1000397217 (20:1681068 A>G), RS1000450687 (20:1660430 C>G), RS1000457737 (20:1676986 G>A), RS1000537367 (20:1661121 C>T), RS1000545787 (20:1639097 T>C), RS1000549613 (20:1630526 G>A,T), RS1000571927 (20:1677293 C>T), RS1000588431 (20:1661342 A>G), RS1000690414 (20:1655238 G>A), RS1000739203 (20:1671598 TG>T), RS1000755057 (20:1634577 A>G), RS1000829942 (20:1650232 C>A), RS1000841577 (20:1665563 C>A)

Disease associations

OMIM: gene MIM:605466 | disease phenotypes:

GenCC curated gene-disease

DiseaseClassificationInheritance
male infertility with azoospermia or oligozoospermia due to single gene mutationLimitedAutosomal recessive

Mondo (1): (MONDO:0018393)

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

7 associations (top):

StudyTraitp-value
GCST001979_3Circulating myeloperoxidase levels (serum)4.000000e-08
GCST005576_19Intracranial aneurysm2.000000e-06
GCST006585_981Blood protein levels2.000000e-19
GCST008499_2Meningococcal C functional antibody titers post childhood immunization7.000000e-07
GCST008499_3Meningococcal C functional antibody titers post childhood immunization8.000000e-06
GCST008499_4Meningococcal C functional antibody titers post childhood immunization6.000000e-07
GCST010396_302Gut microbiota (bacterial taxa, hurdle binary method)5.000000e-06

EFO canonical traits (3, from GWAS)

EFO IDTrait name
EFO:0005243myeloperoxidase measurement
EFO:0004645response to vaccine
EFO:0007874gut microbiome measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

13 total (human), top 13 by PubMed support.

ChemicalActions (top 5)PubMed papers
butyraldehydedecreases expression1
di-n-butylphosphoric acidaffects expression1
CGP 52608affects binding, increases reaction1
(+)-JQ1 compounddecreases expression1
Benzo(a)pyreneaffects methylation, increases methylation1
Diurondecreases expression1
Endosulfandecreases expression1
Formaldehydedecreases expression1
Methyl Methanesulfonatedecreases expression1
Nickelincreases expression1
Valproic Aciddecreases methylation1
Aflatoxin B1decreases methylation1
Cadmium Chlorideincreases expression1

Cellosaurus cell lines

1 cell lines: 1 spontaneously immortalized cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_KA61CHO-K1/SIRP gammaSpontaneously immortalized cell lineFemale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

  • Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): brain aneurysm